https://www.selleckchem.com/pr....oducts/3-deazaadenos
Objectives Our aim was to evaluate subclinical atherosclerosis progression during 5 years of anti-tumour necrosis factor (TNF)-α treatment in psoriatic arthritis (PsA) patients. Methods Thirty-two consecutive PsA patients starting TNF-α inhibitors were enrolled and evaluated at baseline (T, 2 years (FU1) and 5 years (FU2) of treatment. Arterial structural properties were evaluated by B-mode ultrasound of mean carotid intima-media thickness (mean-IMT) and maximum IMT (M-MAX) in each segment (common, bulb, interna
Like
Comment
Share
